CVS Health Corp (NYSE:CVS) price on Thursday, February 06, fall -2.60% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $54.24.
A look at the stock’s price movement, the close in the last trading session was $55.69, moving within a range at $53.84 and $55.98. The beta value (5-Year monthly) was 0.543 while the PE ratio in trailing twelve months stood at 13.78. Turning to its 52-week performance, $80.75 and $43.56 were the 52-week high and 52-week low respectively. Overall, CVS moved 18.38% over the past month.
CVS Health Corp’s market cap currently stands at around $68.26 billion, with investors looking forward to this quarter’s earnings report slated for in March. The company has a Forward Dividend ratio of 2.66, with its dividend yield at 4.90%. As such, investors might be keen on an upside in the stock’s price ahead of the scheduled earnings report.
Analysts have a consensus estimate of 96.9B for the company’s revenue for the quarter, with a low and high estimate of 94.15B and 98.97B respectively. The average forecast suggests up to a 3.29% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 371.65B, representing a 3.88% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CVS is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
20 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 6 analyst(s) rate the stock as a Hold, 14 recommend CVS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CVS’s current price about 0.98% and 4.55% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 54.81, while 7-day volatility ratio is 2.76% and 2.93% in the 30-day chart. Further, CVS Health Corp (CVS) has a beta value of 0.56, and an average true range (ATR) of 1.62. Analysts have given the company’s stock an average 52-week price target of $69, forecast between a low of $66 and high of $82. Looking at the price targets, the low is -21.68% off current price level while to achieve the yearly target high, price needs to move -51.18%. Nonetheless, investors will most likely welcome a -27.21% jump to $69 which is the analysts’ median price.
If we refocus on CVS Health Corp (NYSE:CVS), historical trading data shows that trading volumes averaged 10.96 over the past 10 days and 13.69 million over the past 3 months. The company’s latest data on shares outstanding shows there are 1.26 billion shares.
The 0.20% of CVS Health Corp’s shares are in the hands of company insiders while institutional holders own 81.27% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 16.99 million on 2025-01-15, giving us a short ratio of 1.04. The data shows that as of 2025-01-15 short interest in CVS Health Corp (CVS) stood at 135.0 of shares outstanding, with shares short falling to 19.03 million registered in 2024-12-13. Current price change has pushed the stock 20.83% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CVS stock continues to rise going into the next quarter.
